The growth and rally behind Tesla stock take its backing from the perception of the company by its investors and not necessarily on its auto sales.
Apple is, however, warning that the expected production might be affected by the shortage of key parts.
As the proposal does not include stimulus checks for Americans, US President Donald Trump is calling for other measures to help American families recover from COVID-19.
The official statement discloses that the tokenization will help investors get access to a modernized way of raising funds instead of relying on the traditional method.
This year has been a busy one for the Australian crypto service provider Banxa and there are even more events ahead.
Relief Therapeutics has recorded a 38,300% gain in its year-to-date record. The stock is currently trading at 0.375 Swiss francs.
As part of the massive $39 billion deal, AstraZeneca has agreed to pay a whopping 45% of the share price of Alexion. As per analysts, this could be a win-win situation for both companies.
While the vaccines have given a hint of hope for the economic recovery of most countries including the UK, the ongoing post-Brexit trade talks also have a subtle influence on the global stock market.
Roblox has delayed its public listing for early next year explaining the massive IPO rush has made it difficult to determine the right price for its shares.
According to the FDA, Pfizer’s COVID-19 vaccine is given as two shots administered 21 days apart. One dose is to prime the body, and then a few weeks later, the second dose is to boost the response.
Adam Jonas believes Tesla has the right developmental products in place to open up addressable market opportunities that will help build and sustain its price potential in the future.
The Food and Drug Administration has approved the Pfizer COVID-19 vaccine, paving way for close to three million highly-vulnerable Americans to receive the vaccine next week.
While the technical charts are indication another $100 rally from the current rally some analysts have asked investors to maintain cuation and think that the company is highly overvalued at this stage.
After the Snapchat integration, Twitter is going to launch such integrations with other social media platforms.
Apparently, Sanofi noted that the vaccine was more responsive to younger patients, particularly those below 49 years.